VivoSeq
Other

Spine Fusion

0

Pipeline Programs

5

Active Trials

0

Companies Involved

Spine Fusion is an early-stage landscape with 0 programs across 0 companies.

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

50/100

Attrition Rate

27/100

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

15

clinical trials

Completed4 · 27%
Recruiting3 · 20%
Unknown status2 · 13%
Withdrawn2 · 13%
Not yet recruiting2 · 13%
Terminated2 · 13%

Trial Activity

15 trials

Evaluation of Analgesia for Spine Fusion Elective Surgery in Children
Recruiting··Phase 3·NCT06626503·500 enrolled
Assessing Safety of Cervical Spine Fusion With NMP®
Not yet recruiting·RRed Rock Regeneration Inc.·N/A·NCT07245940·300 enrolled
Steroids After Spine Fusion Surgery
Not yet recruiting·OOregon Health and Science University·Phase 4·NCT04568837·420 enrolled
Use of Forteo (Teriparatide) in Posterolateral Lumbar Spine Fusion
Completed··Phase 4·NCT01292252·36 enrolled
Effect of Platelet-Rich-Plasma in Spine Fusion
Unknown status··Phase 4·NCT03779945·60 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)